Oncology

The PGY2 Oncology Pharmacy residency is a 12-month program providing employment and the academic rank of Clinical Instructor with the University of Oklahoma College of Pharmacy. Residents are primarily involved in clinical practice and investigational drug services at OU Health Stephenson Cancer Center, Oklahoma’s only National Cancer Institute-designated entity. Residents contribute to the education of pharmacy students, resident physicians, medical students, faculty physicians, and other members of the healthcare team. The residency program provides opportunities to practice in interdisciplinary collaborative practice clinics and is designed to meet the individual interests and needs of the resident.



Residency Learning Experiences

During the PGY2 Oncology Pharmacy Residency, you can take advantage of a wide range of oncology learning experiences at OU Health Stephenson Cancer Center, Oklahoma’s only National Cancer Center (NCI)-Designated Cancer Center. Explore extensive oncology pharmacy opportunities including:

Inpatient – Hematology/oncology teaching service, stem cell transplant and cellular therapy, pediatric hematology/oncology

Outpatient – Malignant hematology, stem cell transplant and cellular therapy, breast oncology, gastrointestinal (GI) oncology, thoracic oncology, gynecology/oncology pain and palliative care, investigational drug services

Elective – Inpatient gynecology/oncology, inpatient consult service, benign hematology, infectious disease, oncology informatics, pathology, genitourinary cancer, head and neck cancer, central nervous system (CNS) and melanoma, nutrition

Longitudinal experiences – Infusion center pharmacy, specialty pharmacy, clinical research, student teaching/academia, pharmacy grand rounds

OU Health Stephenson Cancer Center



Residency Program Director

Sarah Schmidt, Pharm.D., BCOP



Accreditation

ASHP-Logo.gif#asset:3216

This residency program is currently in candidate accreditation status through the American Society of Health-System Pharmacists.